J B McGill
Overview
Explore the profile of J B McGill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
McGill J, Bakris G, Fonseca V, Raskin P, Messerli F, Phillips R, et al.
Diabetes Obes Metab
. 2007 Mar;
9(3):408-17.
PMID: 17391169
Aim: The Glycemic Effect in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial compared the metabolic effects of two beta-blockers in people with type 2 diabetes and hypertension treated with...
12.
Brenner B, Cooper M, de Zeeuw D, Grunfeld J, Keane W, Kurokawa K, et al.
J Renin Angiotensin Aldosterone Syst
. 2002 Apr;
1(4):328-35.
PMID: 11967819
The RENAAL Study is a double-blind, placebo-controlled trial to evaluate the renal protective effects of losartan in Type 2 diabetic patients with nephropathy. The study has enrolled 1513 patients and...
13.
McGill J, Reilly P
Clin Ther
. 2001 Jul;
23(6):833-50.
PMID: 11440284
Background: Recent surveys reveal continuing deficiencies in the awareness, treatment, and control of hypertension. In many cases, failure to achieve blood pressure targets may be attributable to the use of...
14.
McGill J, Reilly P
Clin Cardiol
. 2001 Feb;
24(1):66-72.
PMID: 11195609
Background: Hydrochlorothiazide (HCTZ) is commonly used to treat black patients with hypertension. To avoid the metabolic disturbances associated with high-dose HCTZ, blood pressure control may be achieved by combining low...
15.
Lustman P, Griffith L, Clouse R, Freedland K, Eisen S, Rubin E, et al.
Psychosom Med
. 1997 May;
59(3):241-50.
PMID: 9178335
Objective: Depression is a prevalent and chronic condition in diabetes and is associated with poor glucose regulation and poor compliance with diabetes treatment. This investigation evaluated the effects of nortriptyline...
16.
Arfken C, Schmidt L, McGill J, White N, Santiago J
J Diabetes Complications
. 1996 Jan;
10(1):12-7.
PMID: 8639968
The Diabetes Control and Complications Trial has shown that intensive treatment can deter the development and progression of diabetic complications. Integral to intensive treatment is improved glycemic control. To describe...
17.
Laffel L, McGill J, Gans D
Am J Med
. 1995 Nov;
99(5):497-504.
PMID: 7485207
Purpose: To determine whether angiotensin-converting enzyme (ACE) inhibition with captopril reduces the progression of microalbuminuria to overt proteinuria in normotensive patients with insulin-dependent diabetes mellitus (IDDM). Patients And Methods: This...
18.
Lustman P, Griffith L, Clouse R, Freedland K, Eisen S, Rubin E, et al.
Diabetes Care
. 1995 Aug;
18(8):1133-9.
PMID: 7587848
Objective: To determine the effects of alprazolam on glucose regulation in anxious and nonanxious patients with poor glycemic control and establish whether regulatory benefits are related to anxiolytic effects of...
19.
Wagner R, Wear K, Perez J, McGill J, Schechtman K, Miller J
J Am Coll Cardiol
. 1995 Jun;
25(7):1706-11.
PMID: 7759727
Objectives: This work proposes a self-consistent assessment methodology for quantitative evaluation of any combination of diagnostic features, with the immediate goal of quantitatively assessing the discriminating power in diabetic patients...
20.
Coniff R, Shapiro J, Robbins D, Kleinfield R, Seaton T, Beisswenger P, et al.
Diabetes Care
. 1995 Jun;
18(6):817-24.
PMID: 7555508
Objective: To compare the safety and efficacy of three doses of acarbose (100, 200, and 300 mg three times daily) with placebo for the treatment of non-insulin-dependent diabetes mellitus (NIDDM)...